期刊
CURRENT TREATMENT OPTIONS IN NEUROLOGY
卷 16, 期 5, 页码 -出版社
CURRENT MEDICINE GROUP
DOI: 10.1007/s11940-014-0290-9
关键词
Epilepsy; Antiepileptic drugs; Treatment; AED; Childhood absence epilepsy; Juvenile absence epilepsy; Jeavons syndrome
资金
- Citizens United for Research in Epilepsy (CURE)
Over the last one to two decades, several new antiepileptic drugs (AEDs) have become available. These medications have different mechanisms of action, metabolism, efficacy, and side effect profiles. Hence, it has become possible to customize medications for a particular patient. It has also become possible to use various combinations of treatments for refractory epilepsies. As medication options have increased, our goal has shifted to not only to maximize seizure control but also to minimize side effects. However, the older AEDs are still widely used. So the question arises-are newer medications better than older AEDs for the treatment of absence epilepsy? Based on a large multicenter class I study, older AEDs-ethosuximide and valproic acid-are more efficacious than newer AEDs. Due to reduced side effects, ethosuximide remains the first line treatment for childhood absence epilepsy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据